TCI：We Don’t Just Make Products. We Build Human Clinical Evidence.
FROM R&D TO CLINICAL EVIDENCE
As the global health and wellness industry evolves, innovation requires more than novel ingredients and formulations. Scientific research and human clinical evidence are essential to exploring product benefits and delivering meaningful consumer value. TCI continuously invests in human clinical research to strengthen the scientific foundation of product development.
68 Human Clinical Studies: A Sustained Commitment to Research
From 2023 to 2026, TCI accumulated 68 human clinical studies registered within the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) network, averaging approximately 23 studies per year. Under specified search criteria, 740 dietary supplement studies were identified. Comparing TCI’s 68 studies with this dataset yields approximately 9%, or about 9 in every 100 identified studies, reflecting TCI’s sustained commitment to evidence generation.
TCI EVIDENCE ENGINE: From Discovery to Commercialization
TCI EVIDENCE ENGINE connects six stages: Discovery, Mechanism, Formulation, Human Trial, Publication, and Product Commercialization. This integrated R&D approach helps generate scientific evidence, differentiate products, and support credible market communication for brand partners.
Driven by Consumer Needs. Powered by Scientific Evidence.
Looking ahead, TCI will continue integrating global market insights, innovative R&D technologies, and human clinical research to develop science-backed health and wellness solutions. From scientific discovery and human evidence to global commercialization, TCI turns science into meaningful value for consumers worldwide.
